WebOn Feb 08, 2024, Citius Pharmaceuticals ( NASDAQ: CTXR) reported Q4 2024 earnings per share (EPS) of -$0.02, up 66.67% year over year. Total Citius Pharmaceuticals … WebThe 3 analysts offering 12-month price forecasts for Citius Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 4.00. The …
CTXR: Citius Pharmaceuticals - Detailed Earnings Estimates
WebJul 14, 2024 · CTXR Citius Pharmaceuticals $1.28 / -0.015 (-1.16%) 12/01/22 ... Earnings. Fortress Biotech reports Q3 EPS ... Up-to-date information on important industry events Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements. WebCTXR Stock 12 Months Forecast. $5.00. (327.35% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals in the last 3 months. The average price target is $5.00 with a high forecast of $6.00 and a low forecast of $4.00. The average price target represents a 327.35% change from the last price of $1.17. embedding gif into outlook email
Brokers Set Expectations for Citius Pharmaceuticals, Inc.’s Q2 2024 ...
WebApr 2, 2024 · NASDAQ CTXR opened at $1.17 on Friday. The firm has a market cap of $171.12 million, a P/E ratio of -6.50 and a beta of 1.40. The stock’s 50-day moving average is $1.18 and its 200-day moving ... WebCitius Pharmaceuticals Inc (CTXR) Earnings Date. Citius Pharmaceuticals Inc has confirmed Earnings date and time. It is on Thu 11 May (In 51 Days). The Algorithm … WebCheck out the Markets Insider earnings calendar. See who is reporting this week. Find earnings report and search by company, date and market cap. embedding literacy in lessons